Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.25 USD | +0.61% | +12.70% | +26.92% |
Apr. 30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
Apr. 29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.92% | 521M | |
-3.79% | 87.06B | |
+1.45% | 40.25B | |
-15.94% | 31.09B | |
+52.66% | 24.74B | |
-14.50% | 15.91B | |
-9.12% | 11.96B | |
-14.38% | 11.92B | |
-42.56% | 11.61B | |
+4.87% | 8.73B |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- Craig-Hallum Adjusts Avid Bioservices' Price Target to $16 From $22, Maintains Buy Rating